| Literature DB >> 34893567 |
Danah Aljaafari1, Noman Ishaque1, Ghadeer Al-Shabeeb1, Sukainah Alalwi1, Aishah Albakr1, Osama Basheir1, Reem A Alyoubi2, Fahd Alkhamis1, Majed Alabdali1.
Abstract
Introduction: Migraine is a highly prevalent condition, and prevalence of obesity is also increasing. Results of studies addressing association of body mass index (BMI) with migraine and its features are conflicting. In this cross-sectional study, we aim to assess association between BMI and various migraine features.Entities:
Keywords: Body mass index; frequency; migraine; obesity; severity
Mesh:
Year: 2021 PMID: 34893567 PMCID: PMC8693735 DOI: 10.4103/aam.aam_63_20
Source DB: PubMed Journal: Ann Afr Med ISSN: 0975-5764
Patient’s baseline characteristics
| Number of patients (%) | |
|---|---|
| Gender | |
| Females | 96/121 (79.3) |
| Using prophylactic medications | |
| Yes | 106/121 (87.6) |
| Duration | |
| <24 h | 48/121 (39.7) |
| 24- 48 h | 46/121 (38) |
| 48- 72 h or longer | 24/121 (22.3) |
| Unilateral | |
| Yes | 82/121 (67.8) |
| Pulsating | |
| Yes | 98/121 (81) |
| Moderate/severe intensity | |
| Yes | 112/121 (92.6) |
| Avoidance of physical activity | |
| Yes | 89/121 (73.6) |
| Nausea and/or vomiting | |
| Yes | 91/121 (75.2) |
| Photophobia and/or phonophobia | |
| Yes | 111/121 (91.7) |
| Smoking | |
| Never | 104/121 (86) |
| Current | 12/121 (9.9) |
| Ex-smoker | 5/121 (4.1) |
| Exercise | |
| No | 85/121 (70.2) |
| Hormonal use | |
| No | 111/121 (91.7) |
| Chronic medical illness | |
| None | 77/121 (63.6) |
| Hypertension | 13/121 (10.7) |
| Dyslipidemia | 6/121 (5) |
| Hypothyroidism | 4/121 (3.3) |
| Diabetes | 4/121 (3.3) |
| Others | 17/121 (14) |
| BMI | |
| Underweight | 3/121 (2.5) |
| Normal weight | 36/121 (29.8) |
| Overweight | 34/121 (28.1) |
| Obesity | 48/121 (39.7) |
BMI=Body mass index
Body mass index and various patient characteristics and features of migraine
| Underweight (%) | Normal weight (%) | Overweight (%) | Obesity (%) | Total (%) |
| |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Female | 2 (66.7) | 28 (77.8) | 28 (82.4) | 38 (79.2) | 96 (79.3) | 0.911 |
| Male | 1 (33.3) | 8 (22.2) | 6 (17.6) | 10 (20.8) | 25 (20.7) | |
| Use of prophylactic medications | ||||||
| Yes | 3 (100) | 30 (83.3) | 30 (88.2) | 43 (89.6) | 106 (87.6) | 0.749 |
| No | 0 (0) | 6 (16.7) | 4 (11.8) | 5 (10.4) | 15 (12.4) | |
| Duration | ||||||
| <24 h | 1 (33.3) | 19 (52.8) | 14 (41.2) | 14 (29.2) | 48 (39.7) | 0.450 |
| 24- 48 h | 1 (33.3) | 11 (30.6) | 14 (41.2) | 20 (41.7) | 46 (38.0) | |
| 48- 72 h or longer | 1 (33.3) | 6 (16.7) | 6 (17.6) | 14 (29.2) | 27 (22.3) | |
| Unilateral | ||||||
| Yes | 3 (100) | 27 (75) | 22 (64.7) | 30 (62.5) | 82 (67.8) | 0.385 |
| No | 0 (0) | 9 (25) | 12 (35.3) | 18 (37.5) | 39 (32.2) | |
| Pulsating | ||||||
| Yes | 3 (100) | 28 (77.8) | 26 (76.5) | 41 (85.4) | 98 (81) | 0.571 |
| No | 0 (0) | 8 (22.2) | 8 (23.5) | 7 (14.6) | 23 (19) | |
| Moderate/severe | ||||||
| Yes | 2 (66.7) | 35 (97.2) | 32 (94.1) | 43 (89.6) | 112 (92.6) | 0.187 |
| No | 1 (33.3) | 1 (2.8) | 2 (5.9) | 5 (10.4) | 9 (7.4) | |
| Nausea/vomiting | ||||||
| Yes | 3 (100) | 26 (72.2) | 24 (70.6) | 38 (79.2) | 91 (75.2) | 0.582 |
| No | 0 (0) | 10 (27.8) | 10 (29.4) | 10 (20.8) | 30 (24.8) | |
| Photophobia/phonophobia | ||||||
| Yes | 3 (100) | 33 (91.7) | 33 (97.1) | 42 (87.5) | 111 (91.7) | 0.444 |
| No | 0 (0) | 3 (8.3) | 1 (2.9) | 6 (12.5) | 10 (8.3) | |
| Avoidance of daily life activities | ||||||
| Yes | 2 (66.7) | 25 (69.4) | 26 (76.5) | 36 (75) | 89 (73.6) | 0.90 |
| No | 1 (33.31) | 11 (30.6) | 8 (23.5) | 12 (12) | 32 (26.4) | |
| Smoking | ||||||
| Never | 2 (66.7) | 34 (94.4) | 28 (82.4) | 40 (83.3) | 104 (86) | 0.496 |
| Current | 1 (33.3) | 2 (5.6) | 4 (11.8) | 5 (10.45) | 12 (9.9) | |
| Past | 0 (0) | 0 (0) | 2 (5.69) | 3 (6.3) | 5 (4.1) | |
| Exercise | ||||||
| Never | 3 (100) | 25 (69.4) | 23 (67.6) | 34 (70.8) | 85 (70.2) | 0.706 |
| Yes | 0 (0) | 11 (30.6) | 11 (32.4) | 14 (29.2) | 36 (29.8) | |
| Hormonal use | ||||||
| Never | 3 (100) | 32 (88.9) | 31 (91.2) | 45 (93.8) | 111 (91.7) | 0.819 |
| Yes | 0 (0) | 4 (11.1) | 3 (8.8) | 3 (6.3) | 10 (8.3) | |
| Medical illness | ||||||
| None | 3 (100) | 31 (86.1) | 19 (55.9) | 24 (50) | 77 (63.6) | 0.113 |
| Hypertension | 0 (0) | 0 (0) | 4 (11.8) | 9 (18.8) | 13 (10.7) | |
| Dyslipidemia | 0 (0) | 0 (0) | 3 (8.8) | 3 (6.3) | 6 (5) | |
| Hypothyroidism | 0 (0) | 0 (0) | 3 (8.8) | 1 (2.1) | 4 (3.3) | |
| Other | 0 (0) | 4 (11.1) | 4 (11.8) | 9 (18.8) | 17 (14.0) | |
| Diabetes | 0 (0) | 1 (2.8) | 1 (2.9) | 2 (4.2) | 4 (3.3) |